Cargando…
Comparison of Various Phase I Combination Therapy Designs in Oncology for Evaluation of Early Tumor Shrinkage Using Simulations
There is still a lack of efficient designs for identifying the dose response in oncology combination therapies in early clinical trials. The concentration response relationship can be identified using the early tumor shrinkage time course, which has been shown to be a good early response marker of c...
Autores principales: | Seurat, Jérémy, Girard, Pascal, Goteti, Kosalaram, Mentré, France |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762808/ https://www.ncbi.nlm.nih.gov/pubmed/33080100 http://dx.doi.org/10.1002/psp4.12564 |
Ejemplares similares
-
Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models
por: Pantoja, Kristyn, et al.
Publicado: (2022) -
Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics
por: Combes, F P, et al.
Publicado: (2014) -
Systematic comparison of the statistical operating characteristics of various Phase I oncology designs
por: Ananthakrishnan, Revathi, et al.
Publicado: (2016) -
Applying Modeling and Simulations for Rational Dose Selection of Novel Toll‐Like Receptor 7/8 Inhibitor Enpatoran for Indications of High Medical Need
por: Klopp‐Schulze, Lena, et al.
Publicado: (2022) -
On Reverse Shrinkage Effects and Shrinkage Overshoot
por: Jordan, Pascal
Publicado: (2022)